Frontiers in Public Health-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-09-04 膨胀的指挥官来自安徽省

偏重的研究方向：高血压;公共卫生
经验分享：8月26日投完，今天看了下在第三步分配编辑

53 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-01-02 ms5490197991477510 来自江苏省

审稿速度:6.0 | 投稿命中率:5.0
经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-12-04 ms1000001829214282 来自重庆

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心理
经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。

24 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-10-30 Sky2809 来自陕西省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：公共卫生
经验分享：上线后多久可以检索？开检索证明。

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-12-04 ms8000000585743940 来自上海

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：biological age;biomarkers;kidney aging
经验分享：Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-11-24 ms6000001158889404 来自河南省

审稿速度:2.0
经验分享：很快

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-07-06 爱爬树的松鼠

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：公共卫生
经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月

58 0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-06-20 aseasy 来自四川省

送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-06-07 ms7000000669336055

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：公共卫生
经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：体验非常不好，邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人，让你无条件引用他的全部文章，完了之后直接建议拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：公共卫生 经验分享：上线后多久可以检索？开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：biological age;biomarkers;kidney aging 经验分享：Received date: 15 Jul 2023 Editorial assignment start date: 21 Jul 2023 Independent review start date: 04 Oct 2023 Interactive review activated date: 04 Nov 2023 Review finalized date: 30 Nov 2023 Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0 经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生 经验分享：送了两个审稿人，审稿人都同意的情况下主编拒稿，投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人，期间回来一个评价还可以感觉改改能中，然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：公共卫生 经验分享：第一次投在initial validation被直接拒稿，原因是This manuscript does not fulfill the standards established for the journal to be considered for publication，不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康 经验分享：第一次投到第六步了半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-05-12 ms8000001850834002 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：公共健康
经验分享：第一次投到第六步了半个月没动静

55 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务